Embed this press release by copying the code below:

<a class="rwp-pr" href="http://rwire.com/616328">Sales Revenue for Biosimilars in the U.S. Is Expected to Be $1.9 Billion in 2015 and Increase to $11 Billion by 2020, Finds New Report</a><script>!function(){var e="rwp-platform";if(!document.getElementById(e)){var t=document.createElement("script");t.id=e,t.src=("https:"===document.location.protocol?"https":"http")+"://publisher.releasewire.com/embed.js",t.async=!0,document.body.appendChild(t)}}();</script>

Sales Revenue for Biosimilars in the U.S. Is Expected to Be $1.9 Billion in 2015 and Increase to $11 Billion by 2020, Finds New Report